| Financial Year |
March 31 2023 |
| Monetary Funds |
475,448,329.11 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
100,000.00 |
| Accounts Receivable |
452,587,158.16 |
| Advances to Suppliers |
35,030,505.28 |
| Other Receivables |
20,004,629.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
38,595,550.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,825,970.98 |
| Other Current Assets |
29,249,097.99 |
| Total Current Assets |
1,187,359,124.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,889,919.50 |
| Long-term Equity Investment |
59,146,853.55 |
| Investment Properties |
-- |
| Fixed Assetes |
647,634,832.54 |
| Under-construction Projects |
86,823,214.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,629,815.49 |
| R&D expenses |
-- |
| Goodwill |
55,124,628.45 |
| Long-Term Deferred and Prepaid Expenses |
112,997,654.89 |
| Deferred Income Tax Assets |
3,889,539.30 |
| Other Non-Current Assets |
68,524,946.43 |
| Sub-Total of Non-Current Assets |
1,107,308,954.35 |
| Total Assets |
2,294,668,078.49 |
| Short-Term Loans |
153,878,930.79 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,547,900.18 |
| Accounts Payable |
74,595,135.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,520,719.29 |
| Taxes Payable |
9,543,133.06 |
| Interest Payable |
118,055.34 |
| Dividend Payable |
-- |
| Other payables |
18,457,149.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
36,911,779.93 |
| Other Current Liabilities |
1,032,289.91 |
| Sub-Total of Current Liabilities |
311,693,300.56 |
| Long-term Loans |
36,494,230.00 |
| Bonds Payable |
237,791,232.46 |
| Long-Term Accounts Payable |
1,603,435.96 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,929,868.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
296,859,537.57 |
| Total Liabilities |
608,552,838.13 |
| Paid-In Capital(Or Share Stock) |
160,434,469.00 |
| Capital Surplus |
686,186,506.65 |
| Surplus Reserve |
48,629,754.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
611,772,587.56 |
| Minority Stockholder's Interest |
4,685,879.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,681,429,360.48 |
| Owner's Equity（Stockholder's Equity） |
1,686,115,240.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,294,668,078.49 |
